327 related articles for article (PubMed ID: 18798283)
1. The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.
LaPointe NE; Morfini G; Pigino G; Gaisina IN; Kozikowski AP; Binder LI; Brady ST
J Neurosci Res; 2009 Feb; 87(2):440-51. PubMed ID: 18798283
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.
Kanaan NM; Morfini GA; LaPointe NE; Pigino GF; Patterson KR; Song Y; Andreadis A; Fu Y; Brady ST; Binder LI
J Neurosci; 2011 Jul; 31(27):9858-68. PubMed ID: 21734277
[TBL] [Abstract][Full Text] [Related]
3. Frontotemporal Lobar Dementia Mutant Tau Impairs Axonal Transport through a Protein Phosphatase 1γ-Dependent Mechanism.
Combs B; Christensen KR; Richards C; Kneynsberg A; Mueller RL; Morris SL; Morfini GA; Brady ST; Kanaan NM
J Neurosci; 2021 Nov; 41(45):9431-9451. PubMed ID: 34607969
[TBL] [Abstract][Full Text] [Related]
4. Tau binding to microtubules does not directly affect microtubule-based vesicle motility.
Morfini G; Pigino G; Mizuno N; Kikkawa M; Brady ST
J Neurosci Res; 2007 Sep; 85(12):2620-30. PubMed ID: 17265463
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport.
Kanaan NM; Morfini G; Pigino G; LaPointe NE; Andreadis A; Song Y; Leitman E; Binder LI; Brady ST
Neurobiol Aging; 2012 Apr; 33(4):826.e15-30. PubMed ID: 21794954
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of dynein and kinesin motor proteins by tau.
Dixit R; Ross JL; Goldman YE; Holzbaur EL
Science; 2008 Feb; 319(5866):1086-9. PubMed ID: 18202255
[TBL] [Abstract][Full Text] [Related]
7. Fast axonal transport misregulation and Alzheimer's disease.
Morfini G; Pigino G; Beffert U; Busciglio J; Brady ST
Neuromolecular Med; 2002; 2(2):89-99. PubMed ID: 12428805
[TBL] [Abstract][Full Text] [Related]
8. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
[TBL] [Abstract][Full Text] [Related]
9. Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.
Cox K; Combs B; Abdelmesih B; Morfini G; Brady ST; Kanaan NM
Neurobiol Aging; 2016 Nov; 47():113-126. PubMed ID: 27574109
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin.
Cuchillo-Ibanez I; Seereeram A; Byers HL; Leung KY; Ward MA; Anderton BH; Hanger DP
FASEB J; 2008 Sep; 22(9):3186-95. PubMed ID: 18511549
[TBL] [Abstract][Full Text] [Related]
11. Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport.
Morel M; Héraud C; Nicaise C; Suain V; Brion JP
Acta Neuropathol; 2012 Jan; 123(1):71-84. PubMed ID: 22094641
[TBL] [Abstract][Full Text] [Related]
12. Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport.
Tiernan CT; Combs B; Cox K; Morfini G; Brady ST; Counts SE; Kanaan NM
Exp Neurol; 2016 Sep; 283(Pt A):318-29. PubMed ID: 27373205
[TBL] [Abstract][Full Text] [Related]
13. Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport.
Dolma K; Iacobucci GJ; Hong Zheng K; Shandilya J; Toska E; White JA; Spina E; Gunawardena S
Hum Mol Genet; 2014 Mar; 23(5):1121-33. PubMed ID: 24105467
[TBL] [Abstract][Full Text] [Related]
14. Tau directs intracellular trafficking by regulating the forces exerted by kinesin and dynein teams.
Chaudhary AR; Berger F; Berger CL; Hendricks AG
Traffic; 2018 Feb; 19(2):111-121. PubMed ID: 29077261
[TBL] [Abstract][Full Text] [Related]
15. Molecular motors implicated in the axonal transport of tau and alpha-synuclein.
Utton MA; Noble WJ; Hill JE; Anderton BH; Hanger DP
J Cell Sci; 2005 Oct; 118(Pt 20):4645-54. PubMed ID: 16176937
[TBL] [Abstract][Full Text] [Related]
16. The axonal transport motor kinesin-2 navigates microtubule obstacles via protofilament switching.
Hoeprich GJ; Mickolajczyk KJ; Nelson SR; Hancock WO; Berger CL
Traffic; 2017 May; 18(5):304-314. PubMed ID: 28267259
[TBL] [Abstract][Full Text] [Related]
17. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons.
Morfini G; Szebenyi G; Brown H; Pant HC; Pigino G; DeBoer S; Beffert U; Brady ST
EMBO J; 2004 Jun; 23(11):2235-45. PubMed ID: 15152189
[TBL] [Abstract][Full Text] [Related]
18. Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level.
Sengupta A; Novak M; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2006 Oct; 580(25):5925-33. PubMed ID: 17045592
[TBL] [Abstract][Full Text] [Related]
19. Defined Tau Phosphospecies Differentially Inhibit Fast Axonal Transport Through Activation of Two Independent Signaling Pathways.
Morris SL; Tsai MY; Aloe S; Bechberger K; König S; Morfini G; Brady ST
Front Mol Neurosci; 2020; 13():610037. PubMed ID: 33568975
[TBL] [Abstract][Full Text] [Related]
20. Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects.
Falzone TL; Stokin GB; Lillo C; Rodrigues EM; Westerman EL; Williams DS; Goldstein LS
J Neurosci; 2009 May; 29(18):5758-67. PubMed ID: 19420244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
